The study conducted by Yoshimoto et al. presented a mechanism of upregulation of MCL-1 anti-apoptotic protein in FLT3–ITD AML via STAT5 activation, making it a possible pathway for mediating the resistance [98]. Here, FLT3 is linked to acute myeloid leukemia.